JP2024539188A5 - - Google Patents
Info
- Publication number
- JP2024539188A5 JP2024539188A5 JP2024523770A JP2024523770A JP2024539188A5 JP 2024539188 A5 JP2024539188 A5 JP 2024539188A5 JP 2024523770 A JP2024523770 A JP 2024523770A JP 2024523770 A JP2024523770 A JP 2024523770A JP 2024539188 A5 JP2024539188 A5 JP 2024539188A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- composition
- use according
- encoding
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163270929P | 2021-10-22 | 2021-10-22 | |
| US63/270,929 | 2021-10-22 | ||
| PCT/US2022/078551 WO2023070109A1 (en) | 2021-10-22 | 2022-10-21 | Compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539188A JP2024539188A (ja) | 2024-10-28 |
| JP2024539188A5 true JP2024539188A5 (enExample) | 2025-10-29 |
Family
ID=86059748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523770A Pending JP2024539188A (ja) | 2021-10-22 | 2022-10-21 | 肛門高悪性度扁平上皮内病変（ｈｓｉｌ）を治療するための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230233659A1 (enExample) |
| EP (1) | EP4419138A4 (enExample) |
| JP (1) | JP2024539188A (enExample) |
| KR (1) | KR20240099266A (enExample) |
| CN (1) | CN118382457A (enExample) |
| AU (1) | AU2022371672A1 (enExample) |
| CA (1) | CA3235779A1 (enExample) |
| CO (1) | CO2024006161A2 (enExample) |
| MX (1) | MX2024004878A (enExample) |
| WO (1) | WO2023070109A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3421046A1 (en) * | 2014-11-04 | 2019-01-02 | Janssen Vaccines & Prevention B.V. | Therapeutic hpv16 vaccines |
| HK1252967A1 (zh) * | 2015-08-20 | 2019-06-06 | Janssen Vaccines & Prevention B.V. | 治疗性hpv18疫苗 |
| KR20250008956A (ko) * | 2017-05-11 | 2025-01-16 | 이노비오 파마수티컬즈, 인크. | 면역요법 후 고등급 자궁경부 이형성증의 회귀 및 hpv16 및 hpv18 감염의 클리어런스를 위한 임상적 및 면역학적 바이오마커 |
| US20230277645A1 (en) * | 2020-04-02 | 2023-09-07 | Inovio Pharmaceuticals, Inc. | Compositions and methods for treating vulvar dysplasia |
-
2022
- 2022-10-21 CA CA3235779A patent/CA3235779A1/en active Pending
- 2022-10-21 JP JP2024523770A patent/JP2024539188A/ja active Pending
- 2022-10-21 MX MX2024004878A patent/MX2024004878A/es unknown
- 2022-10-21 CN CN202280082724.8A patent/CN118382457A/zh active Pending
- 2022-10-21 EP EP22884739.8A patent/EP4419138A4/en active Pending
- 2022-10-21 KR KR1020247015465A patent/KR20240099266A/ko active Pending
- 2022-10-21 US US18/048,776 patent/US20230233659A1/en active Pending
- 2022-10-21 AU AU2022371672A patent/AU2022371672A1/en active Pending
- 2022-10-21 WO PCT/US2022/078551 patent/WO2023070109A1/en not_active Ceased
-
2024
- 2024-05-15 CO CONC2024/0006161A patent/CO2024006161A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003218787B2 (en) | Virus-like particles of human papillomavirus | |
| CN116082521B (zh) | 痘病毒多抗原嵌合疫苗及其用途 | |
| Jagu et al. | Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines | |
| US6458368B1 (en) | Attenuated microorganism strains expressing HPV proteins | |
| US5648459A (en) | Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | |
| AU729336B2 (en) | Vaccine | |
| JP2019068852A5 (enExample) | ||
| Han et al. | Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes | |
| JP2010516287A5 (enExample) | ||
| JPH05503282A (ja) | 乳頭腫ウイルス誘発腫瘍の予防及び治療のための薬理組成物 | |
| JP2018148890A (ja) | 治療用ｈｐｖ１６ワクチン | |
| JP2006502704A (ja) | Ｈｉｖ調節／アクセサリータンパク質の融合タンパク質 | |
| CA2861021A1 (en) | Immunogenic hpv l2-containing vlps and related compositions and methods | |
| US20250339511A1 (en) | Nucleic acid vaccine against monkeypox virus and use thereof | |
| JP7777890B2 (ja) | Ｃｃｌ１１の用途 | |
| Zhao et al. | Codon usage roles in human papillomavirus | |
| CN119736337A (zh) | Matv51重组腺病毒载体、应用、制备方法及hpv16/18/52治疗性疫苗 | |
| CN101952320B (zh) | 具有免疫原性的物质 | |
| US20050118139A1 (en) | Vaccine using papilloma virus e proteins delivered by viral vector | |
| CN108424925A (zh) | 一种治疗性hpv核酸疫苗 | |
| KR20220090497A (ko) | B형 간염 바이러스 백신 | |
| CN116640787A (zh) | 虹彩病毒dna疫苗 | |
| WO2009090594A2 (en) | Alphavirus based vectors | |
| HK40127535A (en) | Medicine for treating hpv infection related diseases | |
| Guo et al. | Development Status and trend of HPV vaccine |